- Home
- AIZ vs HALO Comparison
AIZ vs HALO Comparison
Compare AIZ & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- HALO
- Stock Information
- Founded
- AIZ 1892
- HALO 1998
- Country
- AIZ United States
- HALO United States
- Employees
- AIZ N/A
- HALO N/A
- Industry
- AIZ Property-Casualty Insurers
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIZ Finance
- HALO Health Care
- Exchange
- AIZ Nasdaq
- HALO Nasdaq
- Market Cap
- AIZ 10.9B
- HALO 9.0B
- IPO Year
- AIZ N/A
- HALO N/A
- Fundamental
- Price
- AIZ $219.23
- HALO $65.64
- Analyst Decision
- AIZ Strong Buy
- HALO Buy
- Analyst Count
- AIZ 7
- HALO 10
- Target Price
- AIZ $235.86
- HALO $73.40
- AVG Volume (30 Days)
- AIZ 318.2K
- HALO 2.2M
- Earning Date
- AIZ 11-04-2025
- HALO 10-30-2025
- Dividend Yield
- AIZ 1.48%
- HALO N/A
- EPS Growth
- AIZ N/A
- HALO 68.93
- EPS
- AIZ 13.78
- HALO 4.37
- Revenue
- AIZ $12,304,900,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- AIZ $7.85
- HALO $32.57
- Revenue Next Year
- AIZ $4.82
- HALO $23.25
- P/E Ratio
- AIZ $15.74
- HALO $15.12
- Revenue Growth
- AIZ 6.42
- HALO 34.97
- 52 Week Low
- AIZ $174.97
- HALO $42.01
- 52 Week High
- AIZ $230.55
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- AIZ 58.06
- HALO 33.99
- Support Level
- AIZ $213.21
- HALO $65.05
- Resistance Level
- AIZ $223.65
- HALO $76.30
- Average True Range (ATR)
- AIZ 3.48
- HALO 2.25
- MACD
- AIZ 0.25
- HALO -1.56
- Stochastic Oscillator
- AIZ 66.18
- HALO 8.34
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.